1. Introduction {#sec1-molecules-21-01299}
===============

*Lawsonia inermis* Linn (Lythraceae) is a tall shrub or small tree native to northern Africa, western and southern Asia, and northern Australasia \[[@B1-molecules-21-01299]\]. *Lawsonia inermis* is a folk herbal medicine used in Taiwan for skin diseases and wounds \[[@B2-molecules-21-01299]\]. Flavonoids, quinoids, naphthalene derivatives, triterpenoids, coumarins \[[@B3-molecules-21-01299]\], and their derivatives are widely distributed in plants of the genus *Lythraceae*. Many of these compound derivatives exhibit anti-inflammatory \[[@B4-molecules-21-01299]\], antibacterial, antifungal, antimycotic, and antiparasitic activities \[[@B5-molecules-21-01299]\]. A continuing chemical investigation of the secondary metabolites of this plant resulted in the isolation and identification of a new diphenol, (*Z*)-4,4′-(prop-1-ene-1,3-diyl)diphenol (**1**), two new isocoumarin carbonates, inermiscarbonates A (**2**) and B (**3**) ([Figure 1](#molecules-21-01299-f001){ref-type="fig"}), as well as six flavonoids (**4**--**9**) from the *Lawsonia inermis*, and their structures are depicted in [Figure 1](#molecules-21-01299-f001){ref-type="fig"}. The isolation and detailed structural elucidation of the (*Z*)-4,4′-(prop-1-ene-1,3-diyl)diphenol (**1**), inermiscarbonates A (**2**), B (**3**), and the anti-inflammatory activities of all isolates are described herein.

2. Results and Discussion {#sec2-molecules-21-01299}
=========================

2.1. Isolation and Structural Elucidation {#sec2dot1-molecules-21-01299}
-----------------------------------------

The MeOH extract of the aerial part of *Lawsonia inermis* was concentrated to give a brown-green residue, which was suspended in water and partitioned with EtOAc and H~2~O, successively. The combined ethyl acetate (EtOAc)-soluble fraction was purified by repeated silica gel column chromatography and normal phase semipreparative high-performance liquid chromatography (HPLC) to obtain a new diphenol, (*Z*)-4,4′-(prop-1-ene-1,3-diyl)diphenol (**1**), two new isocoumarin carbonates, inermiscarbonates A (**2**) and B (**3**), and six known flavonoids, **4**--**9**. The identification of the known compounds was established through direct comparison with the published physical and spectral data.

Compound **1** was obtained as a pale yellow powder. Its molecular formula was calculated as C~15~H~14~O~2~ from the analysis of its high resolution electron spray mass spectrometry (HR-ESI-MS) data, corresponding to nine degrees of unsaturation. The UV spectrum exhibited conjugated absorption at λ (log ε) 285 (4.32) and 296 (4.24) nm. Its IR spectrum showed absorption bands for hydroxyl (3554 cm^−1^), olefinic (1652 cm^−1^), and aromatic (1602 and 1500 cm^−1^) functionalities. Two 1,4-disubstituted benzene rings were suggested from the ^1^H-NMR signals at δ~H~ 7.25 (2H, d, *J* = 8.5 Hz, H-2′, H-6′) and δ~H~ 6.73 (2H, d, *J* = 8.5 Hz, H-3′, H-5′), along with δ~H~ 7.04 (2H, d, *J* = 8.3 Hz, H-2″, H-6″) and δ~H~ 6.68 (2H, d, *J* = 8.3 Hz, H-3″, H-5″). The proton resonances of two olefinic methine (δ~H~ 6.00 (1H, dt, *J* = 10.5, 7.5 Hz, H-2: δ~C~ 142.6) and δ~H~ 5.70 (1H, d, *J* = 10.5 Hz, H-1: δ~C~ 110.5)) and one methylene (δ~H~ 3.57 (2H, d, *J* = 7.5 Hz, H-3)) indicated a partial structure of *cis*-double bond with an adjacent methylene group. The UV absorption at λ~max~ 285 and 296 nm with larger log ε value suggested the conjugated olefinic and phenyl groups. The presence of a 1-propenyl moiety linked between two phenyl moieties in **1** was predicted from the COSY correlations of H-2 (δ~H~ 6.00)/H-1 (δ~H~ 5.70) and H~2~-3 (δ~H~ 3.57)/H-2 (δ~H~ 6.00), as well as the HMBC correlations ([Figure 2](#molecules-21-01299-f002){ref-type="fig"}), as follows: H-1 (δ~H~ 5.70)/C-2′,6′ (δ~C~ 134.1), H-1 (δ~H~ 5.70)/C-3 (δ~C~ 36.8), H~2~-3 (δ~H~ 3.57)/C-1 (δ~C~ 110.5), and H~2~-3 (δ~H~ 3.57)/C-2 (δ~C~ 142.6) ([Table 1](#molecules-21-01299-t001){ref-type="table"}). The connection of the two phenol groups (1,4-disubstituted benzene rings) was determined by the HMBC correlations of H-2″, H-6″ (δ~H~ 7.04)/C-3 (δ~C~ 36.8), H~2~-3 (δ~H~ 3.57)/C-2″, C-6″ (δ~C~ 130.6), and H-2′, H-6′ (δ~H~ 7.25)/C-1 (δ~C~ 110.5). Thus, compound **1** was assigned as (*Z*)-4,4′-(prop-1- ene-1,3-diyl)diphenol.

Inermiscarbonate A (**2**) was isolated as an amorphous powder with molecular formula C~11~H~8~O~5~ as determined by positive-ion HR-ESI-MS, showing an \[M + H\]^+^ ion at *m*/*z* 221.1864 (calcd. for C~11~H~9~O~5~, 221.1861) and eight degrees of unsaturation. The IR spectrum demonstrated the presence of carbonate carbonyl (1793 cm^−1^) and isocoumarin carbonyl groups (1716 cm^−1^) \[[@B6-molecules-21-01299]\]. The UV absorptions at *λ*~max~ (log ε) 244 (4.42), 255 (4.35), 272 (4.46), 281 (4.23), and 350 (3.11) nm indicated that compound **2** possessed isocoumarin with a 3-oxygenated skeleton as 3-methoxy-1*H*-isochromen-1-one (**2a**) \[[@B6-molecules-21-01299]\]. The ^1^H- and ^13^C-NMR data of **2** were similar to those of 3-methoxy-1*H*-isochromen-1-one (**2a**) \[[@B7-molecules-21-01299]\], except that the methyl carbonate group (δ~H~ 3.85 (3H, s, OCOC[H~3~]{.ul}); δ~C~ 52.0 (OCO[C]{.ul}H~3~), 164.1(O[C]{.ul}OCH~3~)) at C-3 of **2** replaced the 3-methoxy group of **2a**. By the aid of HSQC, HMBC ([Figure 3](#molecules-21-01299-f003){ref-type="fig"}), ^1^H--^1^H COSY, and NOESY ([Figure 3](#molecules-21-01299-f003){ref-type="fig"}) techniques, and the full ^1^H- and ^13^C-NMR signals of **2** were unambiguously assigned ([Table 2](#molecules-21-01299-t002){ref-type="table"}). Therefore, the structure of **2** was determined as methyl (4-oxo-1*H*-isochromen-3-yl)carbonate.

Inermiscarbonate (**3**) was isolated as an amorphous powder. Compound **3** shows the molecular formula to be C~12~H~11~O~5~ due to the HR-ESI-MS molecular \[M + H\]^+^ ion at *m*/*z* 235.2129 (calcd. 235.2127), implying eight degrees of unsaturation. The IR spectrum demonstrated the presence of carbonate carbonyl (1772 cm^−1^) and isocoumarin carbonyl groups (1720 cm^−1^) \[[@B6-molecules-21-01299]\]. The UV absorptions at λ~max~ (log ε) 244, 255, 272, 280, and 350 nm were similar to those of **2** and 3-methoxy-1*H*-isochromen-1-one (**2a**), and were characteristic of the 3-oxygenated isocoumarin skeleton \[[@B6-molecules-21-01299]\]. The ^13^C-NMR spectrum of **3** showed signals for 12 carbons which were one more carbon signal than compound **2**. Comparison of the ^1^H-, ^13^C-NMR, and MS data of **3** with those of **2** suggested that their structures were closely related, except that the ethoxy group (δ~H~ 1.36 (t, *J* = 7.3 Hz, OCOCH~2~C[H]{.ul}~3~), 4.30 (q, *J* = 7.3 Hz, OCOC[H]{.ul}~2~CH~3~); δ~C~ 14.3 (OCOCH~2~[C]{.ul}H~3~), 61.0 (OCO[C]{.ul}H~2~CH~3~)) of **3** replaced the methoxy group of **2**. This was supported by HMBC correlation ([Figure 4](#molecules-21-01299-f004){ref-type="fig"}) between OCOC[H]{.ul}~2~CH~3~ (δ~H~ 4.30) and O[C]{.ul}OCH~2~CH~3~ (δ~C~ 163.6). The full assignment of ^1^H- and ^13^C-NMR resonances was supported by ^1^H--^1^H COSY, DEPT, HSQC, NOESY, and HMBC spectral analyses ([Table 3](#molecules-21-01299-t003){ref-type="table"}). According to the above data, the structure of **3** was elucidated as ethyl (1-oxo-1*H*-isochromen-3-yl)carbonate. This is the first isolation of inermiscarbonate B from a natural source, although inermiscarbonate B was synthesized by Schnekenburger \[[@B8-molecules-21-01299]\].

2.2. Structure Identification of the Known Isolates {#sec2dot2-molecules-21-01299}
---------------------------------------------------

The known isolates were readily identified by comparison of their physical and spectroscopic data (UV, IR, ^1^H-NMR, $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$, and MS) with those of the corresponding authentic samples or literature values. They include six flavonoids: 4′-hydroxyflavanone (**4**) \[[@B9-molecules-21-01299]\], apigenine (**5**) \[[@B10-molecules-21-01299]\], kampferol (**6**) \[[@B11-molecules-21-01299]\], luteolin (**7**) \[[@B10-molecules-21-01299]\], quercetin (**8**) \[[@B12-molecules-21-01299]\], and, (−)-catechin (**9**) \[[@B12-molecules-21-01299]\].

2.3. Inhibitory Activity against Nitric Oxide Production {#sec2dot3-molecules-21-01299}
--------------------------------------------------------

Nitric oxide (NO) is derived from the oxidation of [l]{.smallcaps}-arginine by NO synthase (NOS), and is a mediator in the inflammatory response involved in host defense \[[@B13-molecules-21-01299]\]. In inflammation and carcinogenesis conditions, there is an increased production of NO by inducible NO synthase (iNOS) \[[@B14-molecules-21-01299]\]. The anti-inflammatory effects of the compounds isolated from the *Lawsonia inermis* were also evaluated for the suppression of lipopolysaccharide (LPS)-induced NO generation in murine macrophage. In this study, the inhibitory activity of three new compounds (**1**--**3**) and six flavonoids (**4**--**9**) toward NO production was evaluated by the measurement of nitrite/nitrate in LPS-stimulated RAW 264.7 cells. To search for the appropriate concentrations for the above assay, these nine compounds were first tested for their cytotoxic activity against the RAW 264.7 cells, and no significant cytotoxic activities were observed under all tested concentrations. From the results of our anti-inflammatory tests, the following conclusions could be drawn: (a) The high cell viability (\>92%) indicated that the inhibitory activities of compounds **1** and **4**--**9** on LPS-induced NO production did not result from their cytotoxicities; (b) Compounds **1**, **6**, and **7** exhibited inhibitory effects on lipopolysaccharide (LPS)-induced nitric oxide production in RAW 264.7 cells with IC~50~ values of 5.63, 6.67, and 6.17 μg/mL, respectively ([Table 4](#molecules-21-01299-t004){ref-type="table"}). (c) (*Z*)-4,4′-(Prop-1-ene-1,3-diyl)diphenol (**1**) is the most effective among the isolated compounds against LPS-induced NO generation, with IC~50~ = 5.63 ± 3.64 μg/mL.

3. Experimental Section {#sec3-molecules-21-01299}
=======================

3.1. General {#sec3dot1-molecules-21-01299}
------------

UV spectra were obtained with a Shimadzu Pharmaspec-1700 UV-Visible spectrophotometer (Shimadzu, Kyoto, Japan). Infrared spectra were obtained with a Shimadzu IR prestige-21 Fourier transform (FT) infrared spectrophotometer (Shimadzu). 1D- and 2D-NMR spectra were recorded with a Bruker DRX-500 FT-NMR spectrometer (Bruker, Bremen, Germany). Mass spectrometric (HR-EI-MS) data were generated at the Mass Spectrometry Laboratory of the Chung Hsing University (Taichung, Taiwan). Column chromatography was performed using LiChroCART Si gel (5 μM; Merck, Darmstadt, Germany), and TLC analysis was carried out using aluminum pre-coated Si plates (Merck & Co., Inc.), and the spots were visualized using a UV lamp at λ = 254 nm.

3.2. Chemicals {#sec3dot2-molecules-21-01299}
--------------

The solvents used to open column isolation (Sephadex LH 20 and silica gel column) in the study, such as *n*-hexane, chloroform, ethyl acetate, acetone, and methanol were ACS grade. The HPLC grade *n*-hexane, ethyl acetate, and acetone for HPLC isolation, and the deuterated solvent for NMR measurement (CDCl~3~, CD~3~OD) were purchased from the branch of Merck in Taipei, Taiwan. LPS (endotoxin from *Escherichia coli*, serotype 0127:B8), Carr (type IV), indomethacin, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), and other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA).

3.3. Plant Material {#sec3dot3-molecules-21-01299}
-------------------

*Lawsonia inermis* was collected from Neipu Township, Pingtung, Taiwan, in February 2009 and identified by I.-S. Chen (Emeritus Professor, School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan). A voucher specimen (CMU-LIY-090711) was deposited at the School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources.

3.4. Extraction and Isolation {#sec3dot4-molecules-21-01299}
-----------------------------

The dried aerial part (5.0 kg) of *Lawsonia inermis* was extracted three times with MeOH (50 L each) for 7 days. The extract was concentrated under reduced pressure at 35 °C, and the residue (440 g) was partitioned between EtOAc and H~2~O (1:1) to provide the EtOAc-soluble fraction (fraction A; 132.5 g). Fraction A (132.5 g) was purified by column chromatography (CC) (6.0 kg of SiO~2~, 70--230 mesh; *n*-hexane/EtOAc/methanol gradient) to afford 14 fractions: A1--A14.

Fraction A2 (32.8 g) was re-separated by silica gel column chromatography (*n*-hexane:ethyl acetate = 10:1) and semi-preparative normal phase HPLC (*n*-hexane:acetone = 8:1 to afford pure compounds **1** (37.5 mg), **2** (16.8 mg), and **3** (24.1 mg). Fraction 9 (16.45 g) was re-separated by Sephadex LH 20 column chromatography (chloroform:methanol = 3:7), silica gel column chromatography (*n*-hexane:ethyl acetate = 5:2), and then semi-preparative HPLC (*n*-hexane:acetone = 3:1) to afford pure compounds **4** (12.1 mg), **5** (8.5 mg), **6** (16.0 mg), **7** (14.6 mg), **8** (22.6 mg), and **9** (16.3 mg).

*(Z)-4,4′-(Prop-1-ene-1,3-diyl)diphenol* (**1**). Pale yellow powder; HR-ESI-MS: C~15~H~14~O~2~, found: 227.2787 \[M + H\]^+^, calcd.: 227.2784; UV (MeOH) λ~max~ (log ε): 285 (4.32), 296 (4.24) nm. IR (KBr) ν~max~: 3554 (OH), 1652, 1602, 1500, 1439 cm^−1^. ^1^H-NMR and ^13^C-NMR (500/125 MH~Z~, in CDOD) were shown on [Table 1](#molecules-21-01299-t001){ref-type="table"}.

*Methyl (1-oxo-1H-isochromen-3-yl)carbonate (Inermiscarbonate A)* (**2**). Amorphous powder; HR-ESI-MS: C~11~H~9~O~5~, found: 221.1864 \[M + H\]^+^, calcd.: 221.1861; UV (Dioxane) λ~max~ (log ε): 244 (4.42), 255 (4.35), 272 (4.46), 281 (4.23), 350 (3.11) nm. IR (KBr) ν~max~: 1793 (C=O), 1716 (C=O), 1599 cm^−1^. ^1^H-NMR and ^13^C-NMR (500/125 MH~Z~, in CDCl~3~) were shown on [Table 2](#molecules-21-01299-t002){ref-type="table"}.

*Ethyl (1-oxo-1H-isochromen-3-yl)carbonate (Inermiscarbonate B)* (**3**). Amorphous powder; HR-ESI-MS: C~12~H~11~O~5~, found: 235.2129 \[M + H\]^+^, calcd.: 235.2127; UV (Dioxane) λ~max~ (log ε): 244 (4.48), 255 (4.43), 272 (4.55), 280 (4.49), 350 (3.42) nm. IR (KBr) ν~max~: 1772 (C=O), 1720 (C=O), 1598 cm^−1^. ^1^H-NMR and ^13^C-NMR (500/125 MH~Z~, in CDCl~3~) were shown on [Table 3](#molecules-21-01299-t003){ref-type="table"}.

3.5. Cell Culture {#sec3dot5-molecules-21-01299}
-----------------

A murine macrophage cell line RAW 264.7 (BCRC No. 60001) was purchased from the Bioresources Collection and Research Center (BCRC, Hsinchu, Taiwan) of the Food Industry Research and Development Institute (Hsinchu, Taiwan). Cells were cultured in plastic dishes containing Dulbecco's Modified Eagle Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma) in a CO~2~ incubator (5% CO~2~ in air) at 37 °C and subcultured every 3 days at a dilution of 1:5 using 0.05% trypsin-0.02% EDTA in Ca^2+^-, Mg^2+^-free phosphate-buffered saline (DPBS).

3.6. Cell Viability {#sec3dot6-molecules-21-01299}
-------------------

Cells (2 × 10^5^) were cultured in 96-well plates containing DMEM supplemented with 10% FBS for 1 day to become nearly confluent. Then cells were cultured with compounds **1**--**9** in the presence of 100 ng/mL LPS (lipopolysaccharide) for 24 h. After that, the cells were washed twice with DPBS and incubated with 100 μL of 0.5 mg/mL MTT for 2 h at 37 °C, testing for cell viability. The medium was then discarded, and 100 μL dimethyl sulfoxide (DMSO) was added. After 30-min incubation, absorbance at 570 nm was read using a microplate reader (Molecular Devices, Sunnyvale, CA, USA).

3.7. Measurement of Nitric Oxide/Nitrite {#sec3dot7-molecules-21-01299}
----------------------------------------

NO production was indirectly assessed by measuring the nitrite levels in the cultured media and serum determined by a colorimetric method based on the Griess reaction. The cells were incubated with different concentrations of samples in the presence of LPS (100 ng/mL) at 37 °C for 24 h. Then, cells were dispensed into 96-well plates, and 100 μL of each supernatant was mixed with the same volume of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride and 5% phosphoric acid) and incubated at room temperature for 10 min, and the absorbance was measured at 540 nm with a Micro-Reader (Molecular Devices, SpectraMax^®^ M2e, Sunnyvale, CA, USA). By using sodium nitrite to generate a standard curve, the concentration of nitrite was measured from absorbance at 540 nm.

3.8. Statistical Analysis {#sec3dot8-molecules-21-01299}
-------------------------

The data is expressed as means ± standard errors (SE). The IC~50~ values were calculated from the dose curves using a non-linear regression algorithm (SigmaPlot 8.0; SPSS Inc., Chicago, IL, USA, 2002). Statistical evaluation was carried out by one-way analysis of variance (ANOVA followed by Scheffe's multiple range tests).

4. Conclusions {#sec4-molecules-21-01299}
==============

Nine compounds, including three new compounds (**1**--**3**), were isolated from the aerial part of *Lawsonia inermis*. The structures of these compounds were established on the basis of spectroscopic data. New compounds **2** and **3** are carbonate derivatives, with very unique structures from natural sources. Compounds **1** and **4**--**9** showed effective anti-inflammatory activities by decreasing nitrate of LPS-stimulated production in RAW 264.7 cell with IC~50~ values of 5.63 ± 3.64 μg/mL 15.72 ± 2.52 μg/mL, 8.67 ± 3.84 μg/mL, 6.67 ± 3.48 μg/mL, 6.17 ± 2.86 μg/mL, 7.61 ± 3.34 μg/mL, and 14.52 ± 3.31 μg/mL, respectively, wherein compounds **2** and **3** exhibited no inhibition. (*Z*)-4,4′-(Prop-1-ene-1,3-diyl)diphenol (**1**) is a new compound and the most effective among the isolated compounds, with IC~50~ values of 5.63 ± 3.64 μg/mL against LPS-stimulated nitrite generation. Our study suggests *Lawsonia inermis* and its isolates (especially **1**, **6**, and **7**) could be further developed as potential candidates for the treatment or prevention of various inflammatory diseases.
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molecules-21-01299-t001_Table 1

###### 

NMR data (CD~3~OD) of **1**. δ in ppm, *J* in Hz.

  Position   δ~C~    δ~H~                        NOESY       HMBC ^a^
  ---------- ------- --------------------------- ----------- --------------
  1          110.5   5.70 (d, *J* = 10.5 )       2, 2′, 6′   2, 3, 2′, 6′
  2          142.6   6.00 (d, *J* = 10.5, 7.5)   1, 3        1′, 1″
  3          36.8    3.57 (d, *J* = 7.5)         2, 2″, 6″   1, 2, 2″, 6″
  1′         129.0                                           
  2′, 6′     134.1   7.25 (d, *J* = 8.5)         1, 3′, 5′   1, 4′
  3′, 5′     116.7   6.73 (d, *J* = 8.5)         2′, 6′      1′
  4′         157.7                                           
  1″         132.2                                           
  2″, 6″     130.6   7.04 (d, *J* = 8.3)         3, 3″, 5″   3, 4″
  3″, 5″     116.4   6.68 (d, *J* = 8.3)         2″, 6″      1″
  4″         156.8                                           

^a^ From the H- to the C-atom.

molecules-21-01299-t002_Table 2

###### 

NMR data (CDCl~3~) of **2**. δ in ppm, *J* in Hz.

  Position          δ~C~    δ~H~                        NOESY   HMBC ^a^
  ----------------- ------- --------------------------- ------- -----------------
  1                 165.5                                       
  2                                                             
  3                 154.1                                       
  4                 95.6    5.88 (s)                    5       3, 4a, 8a
  4a                138.9                                       
  5                 126.0   7.69 (dd, *J* = 7.1, 1.5)   4, 6    4, 7, 8a
  6                 135.0   7.74 (td, *J* = 7.1, 1.7)   5, 7    8, 4a
  7                 121.2   7.78 (td, *J* = 7.1, 1.5)   6, 8    5, 8a
  8                 132.3   7.99 (dd, *J* = 7.1, 1.7)           1, 6, 4a
  8a                124.7                                       
  O[C]{.ul}OR       164.1                                       
  OCO[CH~3~]{.ul}   52.0    3.85 (s)                            O[C]{.ul}OCH~3~

^a^ From the H- to the C-atom.

molecules-21-01299-t003_Table 3

###### 

NMR data (CDCl~3~) of **3**. δ in ppm, *J* in Hz.

  Position               δ~C~    δ~H~                        NOESY                  HMBC ^a^
  ---------------------- ------- --------------------------- ---------------------- ----------------------
  1                      165.5                                                      
  2                                                                                 
  3                      154.0                                                      
  4                      96.0    5.88 (s)                    5                      3, 4a, 8a
  4a                     139.0                                                      
  5                      126.0   7.69 (dd, *J* = 7.1, 1.5)   4, 6                   4, 7, 8a
  6                      135.0   7.77 (td, *J* = 7.1, 1.7)   5, 7                   8, 4a
  7                      121.2   7.74 (td, *J* = 7.1, 1.5)   6, 8                   5, 8a
  8                      132.3   7.98 (dd, *J* = 7.1, 1.7)                          1, 6, 4a
  8a                     124.8                                                      
  O[C]{.ul}OR            163.6                                                      
  OCO[CH~2~]{.ul}CH~3~   61.0    4.30 (q, *J* = 7.3)         OCOCH~2~C[H~3~]{.ul}   O[C]{.ul}OCH~2~CH~3~
  OCOCH~2~[CH~3~]{.ul}   14.3    1.36 (t, *J* = 7.3)         OCOC[H~2~]{.ul}CH~3~   OCO[C]{.ul}H~2~CH~3~

^a^ From the H- to the C-atom.

molecules-21-01299-t004_Table 4

###### 

Inhibitory effect of compounds **1**--**9** on overproduction of nitric oxide in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells.

  Compounds          IC~50~ (μg/mL) ^a^
  ------------------ --------------------
  **1**              5.63 ± 3.64
  **2**              \>20
  **3**              \>20
  **4**              15.72 ± 2.52
  **5**              8.67 ± 3.84
  **6**              6.67 ± 3.48
  **7**              6.17 ± 2.86
  **8**              7.61 ± 3.34
  **9**              14.52 ± 3.31
  Indomethacin ^b^   78.56 ± 1.38

^a^ The IC~50~ values were calculated from the slope equation of the dose--response curves. Values are expressed as mean S.E.M. of three independent experiments. ^b^ Indomethacin was used as a positive control.

[^1]: These authors contributed equally to this work.
